Z-2203-2023Class II
Medline Probe Cover Kits containing sterile Ultrasound Gel, Labeled as the following: BREAST BIOPSY TRAY...
MEDLINE INDUSTRIES, LP - Northfield / initiated 2023-05-18 / Open, Classified / root cause: design
MEDLINE INDUSTRIES, LP - Northfield began a recall of Medline Probe Cover Kits containing sterile Ultrasound Gel, Labeled as the following: BREAST BIOPSY TRAY, Model Number SPEC0130C on . FDA classified it as Class II and gives the reason as "Probe covers for use during diagnostic ultrasound procedures may have an inadequate barrier at the seams". As of , the recall status on record is Open, Classified, and MDM tags the root cause as design.
Recall record
- Recall number
- Z-2203-2023
- Classification
- Class II
- Status
- Open, Classified
- Initiated
- Posted
- Recalling firm
- MEDLINE INDUSTRIES, LP - Northfield
- Product
- Medline Probe Cover Kits containing sterile Ultrasound Gel, Labeled as the following: BREAST BIOPSY TRAY, Model Number SPEC0130C
- Product code
- PXP Breast Biopsy / Localization Tray
- Reason for recall
- Probe covers for use during diagnostic ultrasound procedures may have an inadequate barrier at the seams.
- Root cause tag
- design
- FDA root cause
- Device Design
- Action
- Medline distributed their recall notices to their consignees beginning on 05/18/2023 by letter. The notices explained the problem, and the risk and requested the destruction of the products. Distributors were directed to notify their consignees, have the customers document and destroy any affected product, and include your customers quantities on the response form. Beginning on 05/23/2023, Medline issued another notice to a separate group of consignees requesting that the kits be over labeled. Distributors were directed to notify the customers and have them return any affected product to the distributor for collection and return to Medline. Questions: please contact the Recall Department at 866-359-1704
- Quantity in commerce
- 1240 units
- Distribution
- Worldwide Distribution: US (Nationwide) and OUS (foreign) United Arab Emirates, Singapore, Lebanon, China Qatar, Costa Rica, India, Canada, Panama & Saudi Arabia.
- Product codes and lots
- All lots within expiry, distributed from Medline between December 2017 - May 2023: Model Number SPEC0130C, UDI/DI (EA) 10193489196641, UDI/DI (CS) 20193489196648
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-2154-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2155-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2156-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2157-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2158-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2159-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2160-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2161-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2162-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2163-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2164-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2165-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2166-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2167-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2168-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2169-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2170-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2171-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2172-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2173-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2174-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2175-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2176-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2177-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2178-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2179-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2180-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2181-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2182-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2183-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2184-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2185-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2186-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2187-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2188-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2189-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2190-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2191-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2192-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2193-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2194-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2195-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2196-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2197-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2198-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2199-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2200-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2201-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2202-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2203-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2204-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2205-2023 | Class II | Ongoing | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
